Clariness, a leading global patient recruitment organisation, has extended its contract with Klinische Forschung Berlin (Klifo Berlin) through listing additional studies on its platform. Clariness’ global patient portal, ClinLife, has so far randomised more than 75 patients for Klifo Berlin.
Klifo Berlin, a professional research site in the capital of Germany, listed several studies on Clariness’ patient-friendly study platform, ClinLife, in March 2021. Since then, more than 75 patients have been enrolled and randomised thanks to Clariness’ innovative digital engagement campaigns and online screening capabilities.
“Clariness has supported us in patient recruitment in nine studies across six different indications, accelerating recruitment, and increasing screening and randomisation numbers,” said Isabelle Schenkenberger, Principal Investigator at Klifo Berlin. “Referrals have been constant and consistent, so we’re excited to see the results of continuing patient recruitment through the ClinLife Registry.”
Moritz Kloss, vice-president of ClinLife Registry, commented, “Our digital targeting and multichannel outreach has extended Klifo Berlin’s patient reach, and driven a significant amount of referrals and randomisations. We’re proud to be continuing our support of Klifo Berlin’s patient recruitment across asthma, COPD, cholesterol/dyslipidaemia and irritable bowel syndrome (IBD), to name a few.”
Clariness’ ClinLife platform is already available in more than 50 countries and 35 different languages, performing recruitment by study and indication to accelerate traditional recruitment timelines. Healthy volunteers and patients who are either suffering from a currently untreatable condition, or dissatisfied with current treatments, can learn more about available studies and enrol in a patient-centric, user-friendly platform.